Clene (CLNNW) Other Current Liabilities : $2.63 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Clene Other Current Liabilities?

Clene's other current liabilities for the quarter that ended in Mar. 2024 was $2.63 Mil.

Clene's quarterly other current liabilities increased from Sep. 2023 ($1.51 Mil) to Dec. 2023 ($2.12 Mil) and increased from Dec. 2023 ($2.12 Mil) to Mar. 2024 ($2.63 Mil).

Clene's annual other current liabilities declined from Dec. 2021 ($2.05 Mil) to Dec. 2022 ($1.49 Mil) but then increased from Dec. 2022 ($1.49 Mil) to Dec. 2023 ($2.12 Mil).

Clene Other Current Liabilities Historical Data

The historical data trend for Clene's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clene Other Current Liabilities Chart

Clene Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Liabilities

Clene Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Current Liabilities	Get a 7-Day Free Trial													-	-	-	-	-

Clene Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Clene Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Clene's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Clene (CLNNW) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clene Inc (NAS:CLNNW) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

CLNN:USA 84C:Germany

Address

6550 South Millrock Drive, Suite G50, Salt Lake City, UT, USA, 84121

Website

https://www.clene.com

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development and commercialization of novel clean-surfaced nanotechnology therapeutics (Drugs, and (2) the development and commercialization of dietary supplements (Supplements).